What is Oncare?
Oncare is at the forefront of providing cutting-edge cancer treatments, integrating the latest research and clinical trials into its patient care. Beyond medical interventions, the company places a strong emphasis on alleviating the mental and emotional toll that a cancer journey can impose. Differentiating itself from larger, impersonal health institutions, Oncare champions a personalized approach, tailoring treatment plans to individual patient needs and ensuring a focused, supportive experience.
How much funding has Oncare raised?
Oncare has raised a total of $1M across 1 funding round:
Angel/Seed
$1M
Angel/Seed (2024): $1M with participation from HuddleVentures, DeVC, TRTL Ventures, and Cloud Capital
Key Investors in Oncare
HuddleVentures
Huddle Ventures is a VC firm dedicated to empowering minority entrepreneurs through access to influencers and smarter wealth growth pathways, focusing on education and economic sustainability for marginalized communities.
DeVC
DeVC is an investment collective of founders, operators, and investors that backs ambitious founders from concept to early traction, committed to helping them build transformative companies.
TRTL Ventures
Undisclosed investor participating in the funding round.
What's next for Oncare?
The substantial enterprise-level funding positions Oncare for significant expansion and innovation in its service offerings. This strategic investment is expected to fuel advancements in treatment methodologies, enhance patient support programs, and potentially broaden the company's reach. With a clear focus on personalized care and research-backed therapies, Oncare is poised to further solidify its impact in the oncology sector, aiming to improve patient outcomes and quality of life.
See full Oncare company page
